台股 » 個股 » 生展 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生展

(8279)
  • 股價
    154.0
  • 漲跌
    ▲2.0
  • 漲幅
    +1.32%
  • 成交量
    9
  • 產業
    上櫃 生技醫療類股▲0.81%
  • 68人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
生展 (8279)籌碼相關-永豐金-忠孝 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-忠孝 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/02/220150.0000.00150.00090.01%
2023/07/3100.001171.50170.50-132-3.13%
2023/07/2800.001173.00170.00-132-3.08%
2023/07/2500.002170.50171.00-238-5.23%
2023/07/1700.001172.50172.00-145-2.22%
2023/07/0500.001172.00172.00-151-1.94%
2023/07/041171.001171.00171.500520.00%
2023/06/2700.001175.00175.00-152-1.92%
2023/06/151172.0000.00172.501521.89%
2023/06/141171.0000.00173.001531.88%
2023/06/133171.5000.00172.003535.57%
2023/06/122171.251171.00171.501531.87%
2023/06/0600.001188.50188.50-153-1.88%
2023/06/051184.5000.00184.501561.78%
2023/05/1700.001184.50185.50-160-1.64%
2023/05/111178.0000.00178.501601.65%
2023/05/0900.000.1184.72181.50-0.159-0.13%
2023/05/0800.000185.50185.00058-0.04%
2023/05/0500.002.2182.07182.00-2.258-3.68%
2023/05/033.1181.5600.00183.503.1585.34%
2023/04/2800.002195.00191.00-254-3.65%
2023/04/192183.5000.00183.502494.07%
2023/04/1800.002178.75180.00-247-4.18%
2023/04/172181.7500.00181.002474.24%
2023/03/080.1173.0000.00170.500.1640.08%
2023/03/070.1178.9900.00177.500.1600.16%
2022/12/2300.001161.00165.50-163-1.57%
2022/12/141157.0000.00155.501601.65%
2022/08/2600.002.2173.14174.50-2.289-2.47%
2022/08/1000.001.1142.61146.00-1.156-1.95%
2022/05/1000.004.5127.00127.00-4.544-10.11%
2022/04/072125.5000.00125.502672.95%
2022/03/1100.001123.00121.50-172-1.39%
2022/03/0900.001113.50113.50-171-1.40%
2022/02/170.5131.6000.00130.500.5680.73%
2022/02/161128.0000.00128.501661.50%
2022/02/0700.001127.00131.00-162-1.60%
2022/01/203125.1700.00128.003456.53%
2021/12/301112.0000.00113.001273.62%
2021/05/1700.00099.50100.500420.00%
2021/05/100108.0000.00107.500410.00%
2021/04/2300.000.1114.00115.00-0.150-0.29%
2021/03/040.1111.5000.00112.000.1480.30%
2020/05/0400.001104.50105.50-195-1.05%
2020/03/2700.00186.8086.00-185-1.17%
2020/03/19178.6000.0074.301841.18%
2020/03/13190.3000.0093.901801.25%
2019/10/2100.001127.00126.50-183-1.20%
2019/10/1800.0013126.42126.00-1386-15.08%
2019/10/1500.000.1126.00126.00-0.192-0.15%
2019/10/077130.3600.00130.507977.18%
2019/10/0400.006132.83130.00-6100-5.95%
2019/09/2012135.0800.00134.001211610.27%
2019/09/091143.0000.00140.5011130.88%
2019/07/3000.001151.50151.00-192-1.08%
2019/07/2500.001153.00153.50-186-1.15%
2019/07/2400.001150.50150.50-184-1.18%
2019/03/2900.000.1113.50113.00-0.150-0.20%
2019/01/2900.001105.00105.50-124-4.06%
2019/01/281102.0000.00106.001234.21%
2018/08/3100.001100.00100.00-161-1.62%
2018/08/231100.0000.00100.501791.27%
2018/08/2100.00199.0099.50-179-1.25%
2018/07/191125.5000.00124.0011290.77%
2018/07/1300.001128.50128.00-1188-0.53%
2018/07/0600.002131.00130.50-2200-1.00%
2018/06/151147.0000.00149.0012820.35%
2018/05/1400.001155.00155.00-1356-0.28%
2018/04/241174.001162.50161.5003740.00%
2018/04/2300.002176.50172.00-2364-0.55%
2018/04/202170.0000.00173.0023420.58%
2018/04/0900.001171.50168.00-1322-0.31%
2018/04/031161.0000.00167.5013150.32%
2018/03/2600.001140.00142.50-1264-0.38%
2018/03/211144.5000.00143.0012670.37%
2018/03/0700.001140.50140.50-1292-0.34%
2018/03/0600.001138.00139.50-1297-0.34%
2018/01/302183.5000.00177.0023240.62%
2018/01/261183.5000.00179.5013210.31%
2018/01/191178.501174.00174.0003100.00%
2018/01/182177.001171.50171.5013000.33%
〈國光生展望〉子公司安特羅腸病毒三期臨床入尾聲 明年展開IPOAnue鉅亨-2023/12/26
〈國光生展望〉流感疫苗申請巴西藥證+破傷風切新市場 外銷業績拚成長Anue鉅亨-2023/12/26
〈聯合再生展望〉洪傳獻:TOPCon技術明年成主流 獲利表現佳Anue鉅亨-2023/10/16
生展 相關文章